G

GEn1E Lifesciences Inc.

15 employees

GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
Artificial Intelligence
Multi-target
Life Science
Immunomodulators
Novel Drugs
Y Combinator
Drug Discovery
Rare Diseases
Clinical Stage
Health Care
ARDS
Next-generation
AI Platform
Drug Development
Inflammation
Techbio
Machine Learning
Inflammatory Disease

Date founded

2018

Funding rounds raised

G

GEn1E Lifesciences Inc. raised undisclosed on August 2, 2021

Investors: 10X Capital

G

GEn1E Lifesciences Inc. raised undisclosed on January 27, 2021

Investors: Bossa Nova Investimentos, Stanford Angels & Entrepreneurs and 10X Capital

G

GEn1E Lifesciences Inc. raised undisclosed on February 12, 2020

Investors: Harmonix

G

GEn1E Lifesciences Inc. raised undisclosed on August 22, 2019

Investors: Khosla Ventures and Y Combinator

FAQ